Astrana Health (NASDAQ:ASTH) CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected first-quarter trends across medical costs, free cash flow and revenue.
Speaking at a Bank of America healthcare event hosted by analyst Craig Jones, Sim described Astrana as a company focused on “realign[ing] the system” through infrastructure intended to improve patient outcomes at lower cost. He said the company has grown rapidly over the past six to seven years, including more than 50% year-over-year growth last year, while remaining profitable and free cash-flow positive.
